The proper effect site concentration of remifentanil for prevention of myoclonus after etomidate injection

Background Etomidate frequently induces myoclonus when administered intravenously with bolus injection during anesthetic induction. This can be bothersome for the anesthesiologist. The dose of remifentanil appropriate for preventing myoclonus without side effects was investigated. Methods All patients with American Society of Anesthesiologists (ASA) physical status I-III were divided into three groups (n = 33 per group) according to the pretreatment effect site concentration of remifentanil (Ultiva, Glaxo-Wellcome, München, Germany) of 0, 2 or 4 ng/ml (Group N: 0 ng/ml, Group R: 2 ng/ml, Group Q: 4 ng/ml) by a target controlled infusion (TCI) system. After a 0.3 mg/kg dose of etomidate was injected intravenously for over 1 minute for anesthetic induction, myoclonus was observed. Before the etomidate injection, the patients were pretreated with remifentanil and their side effects were monitored. Results The number of patients showing myoclonus was significantly different among the groups. The incidence of myoclonus was 81%, 12% and 0% (groups N, R, and Q, respectively, P < 0.01). Side effects including bradycardia and hypotension did not occur in either Group R or Q. Chest wall rigidity occured in 45% of patients in Group Q. Conclusions Administration with a 2 ng/ml effect site concentration of remifentanil could reduce the incidence of myoclonus caused by etomidate bolus injection without chest wall rigidity.

[1]  Ji Hyung Kim,et al.  The effect of remifentanil for reducing myoclonus during induction of anesthesia with etomidate. , 2009, Korean journal of anesthesiology.

[2]  J. Choi,et al.  Pretreatment of rocuronium reduces the frequency and severity of etomidate-induced myoclonus. , 2008, Journal of clinical anesthesia.

[3]  Y. Jeon,et al.  A Comparison of Midazolam with Remifentanil for the Prevention of Myoclonic Movements following Etomidate Injection , 2008, The Journal of international medical research.

[4]  S. Baris,et al.  Remifentanil pretreatment reduces myoclonus after etomidate. , 2006, Journal of clinical anesthesia.

[5]  S. Akıncı,et al.  Magnesium Sulfate Pretreatment Reduces Myoclonus After Etomidate , 2005, Anesthesia and analgesia.

[6]  D. Bredle,et al.  Pretreatment with sufentanil reduces myoclonus after etomidate , 2003, Acta anaesthesiologica Scandinavica.

[7]  K. Schwarzkopf,et al.  Midazolam Pretreatment Reduces Etomidate-induced Myoclonic Movements , 2003, Anaesthesia and intensive care.

[8]  L. Fleisher,et al.  A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter phase IV study. , 2002, Journal of clinical anesthesia.

[9]  J. Scholz,et al.  A comparison of anaesthesia using remifentanil combined with either isoflurane, enflurane or propofol in patients undergoing gynaecological laparoscopy, varicose vein or arthroscopic surgery , 2000, Acta anaesthesiologica Scandinavica.

[10]  C. Hanis,et al.  Alfentanil decreases myoclonus caused by etomidate. , 1999, Middle East journal of anaesthesiology.

[11]  M. Roizen,et al.  Reducing myoclonus after etomidate. , 1999, Anesthesiology.

[12]  J. Bennett,et al.  Difficult or Impossible Ventilation after Sufentanil‐induced Anesthesia Is Caused Primarily by Vocal Cord Closure , 1997, Anesthesiology.

[13]  J. Lerman,et al.  A Randomized Multicenter Study of Remifentanil Compared with Alfentanil, Isoflurane, or Propofol in Anesthetized Pediatric Patients Undergoing Elective Strabismus Surgery , 1997, Anesthesia and analgesia.

[14]  J. Schüttler,et al.  A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery , 1997, Anaesthesia.

[15]  S L Shafer,et al.  Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil: I. Model Development , 1997, Anesthesiology.

[16]  H. Van Aken,et al.  Remifentanil: A Novel, Short-Acting, mu-Opioid , 1996, Anesthesia and analgesia.

[17]  P. Glass,et al.  Preliminary Pharmacokinetics and Pharmacodynamics of an Ultra‐Short‐Acting Opioid: Remifentanil (GI87084B) , 1993, Anesthesia and analgesia.

[18]  S. Moorthy,et al.  Excitatory Effects and Electroencephalographic Correlation of Etomidate, Thiopental, Methohexital, and Propofol , 1993, Anesthesia and analgesia.

[19]  B. Mets,et al.  Another complication of opiate-induced chest wall rigidity. , 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[20]  P. White,et al.  Pro‐ and Anticonvulsant Effects of Anesthetics (Part II) , 1990, Anesthesia and analgesia.

[21]  B. Partridge,et al.  Comparison of Pretreatments to Prevent the Cardiovascular Response to ECT , 1990 .

[22]  N. Pace,et al.  Fentanyl Pretreatment Modifies Anaesthetic Induction with Etomidate , 1988, Anaesthesia and intensive care.

[23]  N. D. Kien,et al.  Intracranial pressure increases during alfentanil-induced rigidity. , 1988, Anesthesiology.

[24]  H. Arandia,et al.  Glottic closure following large doses of fentanyl. , 1987, Anesthesiology.

[25]  R. Lesser,et al.  Effect of Etomidate on the Electroencephalogram of Patients with Epilepsy , 1986, Anesthesia and analgesia.

[26]  N. T. Smith,et al.  Physiology of Alfentanil‐induced Rigidity , 1986, Anesthesiology.

[27]  B. Vandijk.  Venous pain and involuntary muscular movements during and after administration of etomidate. A comparison of two different formulations. , 1978 .

[28]  B. van Dijk.  Venous pain and involuntary muscular movements during and after administration of etomidate. A comparison of two different formulations. , 1978, Der Anaesthesist.

[29]  M. Ghoneim,et al.  Etomidate: A Clinical and Electroencephalographic Comparison with Thiopental , 1977, Anesthesia and analgesia.

[30]  J. Whitwam,et al.  Effect of dose and premedication on induction complications with etomidate. , 1976, British journal of anaesthesia.